Literature DB >> 16298235

Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.

Katharina Buerger1, Markus Otto, Stefan J Teipel, Raymond Zinkowski, Kaj Blennow, John DeBernardis, Daniel Kerkman, Johannes Schröder, Peter Schönknecht, Lukas Cepek, Cheryl McCulloch, Hans-Jürgen Möller, Jens Wiltfang, Hans Kretzschmar, Harald Hampel.   

Abstract

To study the potential diagnostic value of abnormally phosphorylated tau protein in Creutzfeldt-Jakob disease (CJD) compared to Alzheimer's disease (AD), we determined levels of tau phosphorylated at threonine 231 (p-tau231) and of total tau (t-tau) in cerebrospinal fluid (CSF) of CJD patients, AD patients, and healthy controls (HC). CJD patients showed excessively high t-tau levels but relatively low p-tau(231) concentrations compared to the AD group. t-tau alone yielded the best diagnostic accuracy to differentiate between CJD and AD patients, when compared to p-tau231 and the p-tau231/t-tau ratio (97, 78, and 95% correctly allocated cases, respectively). Our findings indicate a dissociation in the direction of change in CSF levels of t-tau and p-tau231 in CJD when compared to AD.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16298235     DOI: 10.1016/j.neurobiolaging.2004.12.003

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  26 in total

Review 1.  Laboratory biomarkers in Alzheimer's disease.

Authors:  Joshua R Steinerman; Lawrence S Honig
Journal:  Curr Neurol Neurosci Rep       Date:  2007-09       Impact factor: 5.081

2.  Plasma phospho-tau181 increases with Alzheimer's disease clinical severity and is associated with tau- and amyloid-positron emission tomography.

Authors:  Michelle M Mielke; Clinton E Hagen; Jing Xu; Xiyun Chai; Prashanthi Vemuri; Val J Lowe; David C Airey; David S Knopman; Rosebud O Roberts; Mary M Machulda; Clifford R Jack; Ronald C Petersen; Jeffrey L Dage
Journal:  Alzheimers Dement       Date:  2018-04-05       Impact factor: 21.566

3.  CSF Tau proteins reduce misdiagnosis of sporadic Creutzfeldt-Jakob disease suspected cases with inconclusive 14-3-3 result.

Authors:  M J Leitão; I Baldeiras; M R Almeida; M H Ribeiro; A C Santos; M Ribeiro; J Tomás; S Rocha; I Santana; C R Oliveira
Journal:  J Neurol       Date:  2016-06-29       Impact factor: 4.849

4.  Longitudinal CSF isoprostane and MRI atrophy in the progression to AD.

Authors:  M J de Leon; L Mosconi; J Li; S De Santi; Y Yao; W H Tsui; E Pirraglia; K Rich; E Javier; M Brys; L Glodzik; R Switalski; L A Saint Louis; D Pratico
Journal:  J Neurol       Date:  2007-11-14       Impact factor: 4.849

Review 5.  Peptides and proteins in plasma and cerebrospinal fluid as biomarkers for the prediction, diagnosis, and monitoring of therapeutic efficacy of Alzheimer's disease.

Authors:  Christopher D Aluise; Renã A Sowell; D Allan Butterfield
Journal:  Biochim Biophys Acta       Date:  2008-08-07

6.  Hypometabolism and altered cerebrospinal fluid markers in normal apolipoprotein E E4 carriers with subjective memory complaints.

Authors:  Lisa Mosconi; Susan De Santi; Miroslaw Brys; Wai H Tsui; Elizabeth Pirraglia; Lidia Glodzik-Sobanska; Kenneth E Rich; Remigius Switalski; Pankaj D Mehta; Domenico Pratico; Ray Zinkowski; Kay Blennow; Mony J de Leon
Journal:  Biol Psychiatry       Date:  2007-08-27       Impact factor: 13.382

7.  Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.

Authors:  Maartje I Kester; Charlotte E Teunissen; Daniel L Crimmins; Elizabeth M Herries; Jack H Ladenson; Philip Scheltens; Wiesje M van der Flier; John C Morris; David M Holtzman; Anne M Fagan
Journal:  JAMA Neurol       Date:  2015-11       Impact factor: 18.302

8.  Neurochemical dementia diagnostics: a simple algorithm for interpretation of the CSF biomarkers.

Authors:  Piotr Lewczuk; Rüdiger Zimmermann; Jens Wiltfang; Johannes Kornhuber
Journal:  J Neural Transm (Vienna)       Date:  2009-08-04       Impact factor: 3.575

9.  Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.

Authors:  Inês Esteves Baldeiras; Maria Helena Ribeiro; Paula Pacheco; Alvaro Machado; Isabel Santana; Luís Cunha; Catarina Resende Oliveira
Journal:  J Neurol       Date:  2009-05-06       Impact factor: 4.849

10.  Current Challenges for the Early Detection of Alzheimer's Disease: Brain Imaging and CSF Studies.

Authors:  Rachel Mistur; Lisa Mosconi; Susan De Santi; Marla Guzman; Yi Li; Wai Tsui; Mony J de Leon
Journal:  J Clin Neurol       Date:  2009-12-31       Impact factor: 3.077

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.